68Ga-NOTA-RM26: Clinical Trials

5 trials of 68Ga-NOTA-RM26, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 recruiting. 4 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Unknown 3, Recruiting 1
Phase 11Unknown 1

Follow 68Ga-NOTA-RM26: new trials by email Literature Review of 68Ga-NOTA-RM26 trials Research Report on 68Ga-NOTA-RM26

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-NOTA-RM26 PET/CT in Glioma Patients
68Ga-RM26 - Glioma
Early Phase 1UnknownPeking Union Medical College Hospital302022-10-012024-05-14
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26 - Breast Cancer, Prostate Cancer
Early Phase 1RecruitingPeking Union Medical College Hospital902022-08-162024-07-05
68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor
68Ga-NOTA-RM26 - Gastrointestinal Stromal Tumors
Early Phase 1UnknownPeking Union Medical College Hospital302021-05-012021-08-11
68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients
68Ga-NOTA-RM26 - Prostate Cancer
Phase 1UnknownPeking Union Medical College Hospital302016-11-012017-05-24
68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients
68Ga-NOTA-RM26 - Breast Tumor
Early Phase 1UnknownPeking Union Medical College Hospital302016-10-012017-11-20

Conditions studied

Breast Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Glioma (1)

Sponsors

Peking Union Medical College Hospital (5)

Countries

China (5)

Top investigators

Zhaohui Zhu, MD,PHD (2)  ·  Zhaohui Zhu (1)  ·  Zhaohui Zhu, M.D.,PhD. (1)

Results publications

PMID 39448271, PMID 39806560, PMID 39821814

NIH funding

ZIAEB000073 (1)